Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis in gram-positive bacteria by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors. This sterically hinders transglycosylase and transpeptidase, preventing cell wall elongation and cross-linking. The patient's symptoms are characteristic of red man syndrome, a rate-dependent infusion reaction caused by widespread histamine release, which is a common side effect of vancomycin.

Gentamicin is an aminoglycoside. These antibiotics bind irreversibly to the 16S rRNA of the 30S ribosomal subunit, which leads to misreading of the mRNA codon and the production of faulty proteins, as well as premature termination of translation. Ototoxicity and nephrotoxicity are well-known adverse effects of aminoglycosides.

Ceftriaxone is a third-generation cephalosporin, which is a class of beta-lactam antibiotics. Like other beta-lactams, its mechanism of action involves binding to and inactivating penicillin-binding proteins (PBPs), primarily transpeptidases. This inhibition prevents the final cross-linking step of peptidoglycan synthesis, compromising the integrity of the bacterial cell wall and leading to bacteriolysis.

Amphotericin B's primary antifungal mechanism is binding to ergosterol, the main sterol in fungal cell membranes, forming pores that lead to ion leakage and cell death. However, it can also bind to cholesterol in mammalian cell membranes, albeit with lower affinity. This binding in human renal tubular cells disrupts membrane integrity, leading to electrolyte wasting (hypokalemia, hypomagnesemia) and renal vasoconstriction, which together cause its characteristic nephrotoxicity.

Terbinafine is an allylamine antifungal that works by inhibiting squalene epoxidase, a key enzyme in the ergosterol synthesis pathway. This inhibition leads to a deficiency of ergosterol and a toxic accumulation of squalene within the fungal cell, which disrupts membrane function and leads to cell death. Terbinafine is highly lipophilic and keratophilic, allowing it to concentrate in nails and skin.

Caspofungin is an echinocandin antifungal. Echinocandins work by noncompetitively inhibiting the enzyme beta-(1,3)-D-glucan synthase. This disrupts the synthesis of beta-glucan, an essential polysaccharide component of the fungal cell wall (but not human cells). The resulting weakened cell wall leads to osmotic instability and fungal cell death.

Imipenem, a broad-spectrum carbapenem antibiotic, is rapidly inactivated in the renal tubules by a human enzyme called dehydropeptidase I. Cilastatin is an inhibitor of this enzyme. By co-administering cilastatin, the inactivation of imipenem is blocked, which increases its half-life and allows it to achieve effective therapeutic concentrations in the urine and systemic circulation.

Amoxicillin is a beta-lactam antibiotic. Beta-lactams work by irreversibly inhibiting transpeptidase (also known as penicillin-binding protein), an enzyme crucial for the final step of peptidoglycan synthesis. This inhibition weakens the bacterial cell wall, leading to cell lysis and death.

Ciprofloxacin is a fluoroquinolone antibiotic. Fluoroquinolones exert their bactericidal effect by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes necessary for DNA replication, transcription, and repair. A well-known, though rare, adverse effect of fluoroquinolones is tendonitis and tendon rupture, particularly of the Achilles tendon.

TMP-SMX works by sequentially inhibiting two key enzymes in the bacterial and protozoal folate synthesis pathway. Sulfamethoxazole (a sulfonamide) competes with para-aminobenzoic acid (PABA) to inhibit dihydropteroate synthase. Trimethoprim inhibits dihydrofolate reductase. This dual blockade prevents the synthesis of tetrahydrofolate, a crucial cofactor for purine and thymidine synthesis, leading to a bactericidal effect.